Public filings / COGT on Yahoo Finance (opens in a new tab)
COGT: insider buying, 13F holders, analyst moves
Cogent Biosciences Inc
A summary of public filings about Cogent Biosciences Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold COGT
Combined reported value $365.8M.
Holders among our 100 managers: 6 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Deerfield Company | $193.7M | 2.02% | Trimmed |
| RTW Investments | $89.4M | 0.76% | Trimmed |
| Deep Track Capital | $77.4M | 1.14% | Added |
| Perceptive Advisors | $4.7M | 0.07% | Unchanged |
| Farallon Capital | $658K | 0.00% | Unchanged |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.